About DEVA Holding
DEVA, which started operations in 1958, is one of Turkey’s well-established pharmaceutical manufacturers. Its main activity is the production and marketing of human medicines and raw materials, and it also produces veterinary medicines, cologne and medical ampoules.
DEVA enriches its product range every year and has more than 650 products in 14 therapeutic areas, from oncology to cardiology and from the respiratory system to ophthalmology. With growing regional operations and exports, it holds 1,029 product licences in 69 countries, including the United States, Switzerland, Germany, the Netherlands and the United Kingdom.
DEVA Holding’s facilities have received European GMP and US FDA conformity approval. In its award-winning DEVARGE Center, trained specialists develop innovative new forms and products with high added value in laboratories and production areas equipped with up-to-date technology.
DEVA has become the most comprehensive domestic pharmaceutical company in Turkey. Its production facilities in Çerkezköy and Kartepe have an annual capacity of 578 million boxes of medicine.